Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apo Flurazepam
2. Apo-flurazepam
3. Dalmadorm
4. Dalmane
5. Dihydrochloride, Flurazepam
6. Dormodor
7. Flurazepam
8. Flurazepam Dihydrochloride
9. Flurazepam Hydrochloride
10. Flurazepam Mono Perchlorate
11. Flurazepam Mono-perchlorate
12. Hydrochloride, Flurazepam
13. Mono-perchlorate, Flurazepam
14. Monohydrochloride, Flurazepam
15. Staurodorm
1. 36105-20-1
2. Dalmate
3. 7c4jh842ij
4. Dalmadorm
5. Dalmane
6. Felison
7. Linzac
8. Natam
9. Insumin Dihydrochloride
10. 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3h-1,4-benzodiazepin-2-one;hydrochloride
11. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, Monohydrochloride
12. 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride
13. 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride
14. Id 480
15. Einecs 252-867-1
16. Unii-7c4jh842ij
17. Fluzepam
18. Dalmate (tn)
19. Fluorazepam Hydrochloride
20. Schembl29794
21. Chebi:31626
22. Flurazepam Hydrochloride (jp17)
23. Dtxsid40189686
24. Nsc78559
25. Flurazepam Monohydrochloride [mart.]
26. D01408
27. Flurazepam Monohydrochloride [ep Monograph]
28. Q27268050
29. Wln: T67 Gnv Jn Ihj Cg G2n2&2 Kr Bf &gh 2
30. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, Dihydrochloride
31. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-, Dihydrochloride
32. 2h-1, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-,1,3-dihydro-, Dihydrochloride
33. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, Hydrochloride (1:1)
34. 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,4-benzodiazepin-2-one Dihydrochloride
35. Flurazepam Monohydrochloride; 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2h-benzo-1,4-diazepin-2-one Monohydrochloride; 2h-1,4-benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-,1,3-dihydro-, Dihydrochloride
Molecular Weight | 424.3 g/mol |
---|---|
Molecular Formula | C21H24Cl2FN3O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 423.1280459 g/mol |
Monoisotopic Mass | 423.1280459 g/mol |
Topological Polar Surface Area | 35.9 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 540 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Flurazepam hydrochloride |
Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
Active Ingredient | Flurazepam hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 30mg; 15mg |
Market Status | Prescription |
Company | Mylan Pharms |
2 of 2 | |
---|---|
Drug Name | Flurazepam hydrochloride |
Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
Active Ingredient | Flurazepam hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 30mg; 15mg |
Market Status | Prescription |
Company | Mylan Pharms |
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
ABOUT THIS PAGE
A Flurazepam Monohydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flurazepam Monohydrochloride, including repackagers and relabelers. The FDA regulates Flurazepam Monohydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flurazepam Monohydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flurazepam Monohydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flurazepam Monohydrochloride supplier is an individual or a company that provides Flurazepam Monohydrochloride active pharmaceutical ingredient (API) or Flurazepam Monohydrochloride finished formulations upon request. The Flurazepam Monohydrochloride suppliers may include Flurazepam Monohydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Flurazepam Monohydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flurazepam Monohydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Flurazepam Monohydrochloride Certificate of Suitability (COS). The purpose of a Flurazepam Monohydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Flurazepam Monohydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Flurazepam Monohydrochloride to their clients by showing that a Flurazepam Monohydrochloride CEP has been issued for it. The manufacturer submits a Flurazepam Monohydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Flurazepam Monohydrochloride CEP holder for the record. Additionally, the data presented in the Flurazepam Monohydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Flurazepam Monohydrochloride DMF.
A Flurazepam Monohydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Flurazepam Monohydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Flurazepam Monohydrochloride suppliers with CEP (COS) on PharmaCompass.
A Flurazepam Monohydrochloride written confirmation (Flurazepam Monohydrochloride WC) is an official document issued by a regulatory agency to a Flurazepam Monohydrochloride manufacturer, verifying that the manufacturing facility of a Flurazepam Monohydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flurazepam Monohydrochloride APIs or Flurazepam Monohydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Flurazepam Monohydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Flurazepam Monohydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Flurazepam Monohydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flurazepam Monohydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flurazepam Monohydrochloride GMP manufacturer or Flurazepam Monohydrochloride GMP API supplier for your needs.
A Flurazepam Monohydrochloride CoA (Certificate of Analysis) is a formal document that attests to Flurazepam Monohydrochloride's compliance with Flurazepam Monohydrochloride specifications and serves as a tool for batch-level quality control.
Flurazepam Monohydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Flurazepam Monohydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flurazepam Monohydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Flurazepam Monohydrochloride EP), Flurazepam Monohydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flurazepam Monohydrochloride USP).
LOOKING FOR A SUPPLIER?